You are here: Industry Insights > vaccine

News List

COVID-19: UK commits £210m as pharmacist warns Brits not to stockpile Ventolin inhalers pharmatimes
March 30, 2020
Amidst the growing “unprecedented circumstances”, the UK government has said it will contribute £210 million toward international efforts aimed at finding a vaccine against the novel virus.
Sartorius Supports Development of Vaccine Candidate against Coronavirus americanpharmaceuticalreview
March 30, 2020
Sartorius has supported CanSino Biologics and Maj. Gen. Chen Wei’s team at the Institute of Bioengineering at the Academy of Military Medical Sciences ...
Biopharma industry leaders collaborate to combat COVID-19 europeanpharmaceuticalreview
March 30, 2020
The International Federation of Pharmaceutical Manufacturers and Associations has announced that the biopharma industry has responding swiftly to the COVID-19 pandemic and will further increase its efforts.
UK pledges £210m to CEPI for Covid-19 vaccine development pharmaceutical-technology
March 30, 2020
Non-profit the Coalition for Epidemic Preparedness Innovations (CEPI) has received £210m from the UK Government to support efforts to develop a Covid-19 vaccine.
Dynavax teams up with CEPI for Covid-19 vaccine pharmaceutical-technology
March 30, 2020
Dynavax Technologies has partnered with the Coalition for Epidemic Preparedness Innovations (CEPI) to create a vaccine against Covid-19 infection.
Hoth Therapeutics announces agreement to joint development for a self-assembling vaccine (SAV) for the potential prevention of coronavirus pharmaceutical-business-review
March 27, 2020
Hoth Therapeutics has reached an agreement with Voltron Therapeutics to form a joint venture entity, to be named HaloVax, to commence preclinical studies.
Novavax plans FDA filing after NanoFlu trumps Sanofi flu vaccine pharmatimes
March 27, 2020
Novavax has unveiled new Phase III data showing that its recombinant quadrivalent seasonal influenza vaccine candidate, NanoFlu, met all primary endpoints in adults aged 65 and older against Sanofi’s Fluzone Quadrivalent.
Medicago announces production of a viable vaccine candidate for COVID-19 expresspharma
March 27, 2020
The biopharma successfully produced Virus-Like Particles (VLP) of the coronavirus in just 20 days using proprietary plant-based technology Medicago’s platform can produce both vaccine and antibody candidates against COVID-19 disease.
COVID-19: UK clinical tests to start next month as global authorities see spike in unauthorised meds pharmatimes
March 26, 2020
As the NHS announces a new major deal to expand hospital capacity to combat the spreading virus, clinical testing for vaccine candidates in the UK is being slated to start as early as next month.
Sartorius Supports Coronavirus Vax Candidate contractpharma
March 26, 2020
BIOSTAT STR single-use bioreactor system used for the upstream preparation of the recombinant vaccine.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 100 101 Next page